NASDAQ · BRKRP
Healthcare · Medical - Devices
$470.52
Up+$1.95 (+0.42%)
Updated Sep 26, 2026, 10:19 PM
SID Score
7.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
BRKRP closed at $470.52 after 20 trading sessions, up 11.94% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $472.03 | $473.91 | $465.86 | $470.52 | 2.07K |
| Sep 24, 2026 | $457.35 | $475.20 | $448.03 | $468.57 | 26.33K |
| Sep 23, 2026 | $447.09 | $448.37 | $439.16 | $439.16 | 1.78K |
| Sep 22, 2026 | $453.98 | $454.50 | $453.97 | $454.50 | 3.73K |
| Sep 21, 2026 | $452.66 | $457.31 | $452.66 | $456.63 | 8.95K |
| Sep 18, 2026 | $463.67 | $463.67 | $446.74 | $447.04 | 15.73K |
| Sep 17, 2026 | $455.25 | $471.24 | $455.25 | $464.27 | 22.52K |
| Sep 16, 2026 | $429.28 | $452.98 | $429.28 | $447.07 | 19.03K |
| Sep 15, 2026 | $404.57 | $419.72 | $402.88 | $416.80 | 7.28K |
| Sep 14, 2026 | $389.37 | $393.13 | $387.52 | $393.06 | 1.92K |
| Sep 11, 2026 | $397.51 | $400.605 | $397.51 | $399.57 | 1.05K |
| Sep 10, 2026 | $396.17 | $396.17 | $395.14 | $395.14 | 760.42 |
| Sep 9, 2026 | $410.55 | $413.93 | $399.27 | $406.23 | 2.78K |
| Sep 8, 2026 | $421.57 | $431.41 | $420.7201 | $431.41 | 5.85K |
| Sep 4, 2026 | $437.51 | $437.64 | $431.72 | $431.72 | 1.68K |
| Sep 3, 2026 | $435.30 | $438.00 | $426.08 | $438.00 | 1.43K |
| Sep 2, 2026 | $431.42 | $435.95 | $431.42 | $435.53 | 1.09K |
| Sep 1, 2026 | $422.33 | $428.01 | $415.16 | $415.16 | 1.72K |
| Aug 31, 2026 | $421.31 | $430.16 | $417.41 | $428.01 | 7.9K |
| Aug 28, 2026 | $433.19 | $433.21 | $420.32 | $420.32 | 950.46 |
The latest Smart Investors Daily articles mentioning BRKRP.
BRKRP research
Company profile and research snapshot.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 9, 2026 | UBS | Neutral | — |
| Aug 5, 2026 | Citigroup | Neutral | — |
| Jul 8, 2026 | Citigroup | Neutral | — |
| Jul 7, 2026 | Leerink Partners | Outperform | — |
| Jun 29, 2026 | Guggenheim | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Sep 22, 2026
Bruker Corporation (BRKR) Bank of America Global Healthcare Conference 2026 September 22, 2026 6:45 AM EDTCompany ParticipantsGerald Herman - Executive VP...
Yahoo · Sep 21, 2026
Bruker Corporation previously announced a multi-system order worth more than US$6.00 million from the University of California, Berkeley to equip the Pines Magnetic Resonance Center with next-generation high-field NMR instrumentation, including an AV NEO-X 800 MHz spectrometer with a cryogenically cooled MAS CryoProbe and multiple supporting systems, scheduled for delivery in 2027. This large academic investment highlights how Bruker’s advanced NMR platforms are being embedded in...
Yahoo · Sep 21, 2026
BERKELEY, Calif., September 21, 2026--Bruker Corporation (Nasdaq: BRKR) today announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to next-generation NMR technologies, including 800 MHz–class instrumentation. These capabilities strengthen research in chemistry, materials science, structural biology, and related fields across UC Berkeley
SeekingAlpha · Sep 16, 2026
Bruker Corporation (BRKR) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 10:45 AM EDTCompany ParticipantsFrank Laukien -...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BRKRP.
